4O5L
Crystal structure of broadly neutralizing antibody F045-092
4O5L の概要
| エントリーDOI | 10.2210/pdb4o5l/pdb |
| 関連するPDBエントリー | 4O58 4O5I |
| 分子名称 | Fab F045-092 light chain, Fab F045-092 heavy chain, PHOSPHATE ION, ... (4 entities in total) |
| 機能のキーワード | fab, fragment antigen binding, immunoglobulin fold, immune system |
| 由来する生物種 | Homo sapiens (human) 詳細 |
| 細胞内の位置 | Secreted : P0DOY3 |
| タンパク質・核酸の鎖数 | 2 |
| 化学式量合計 | 49895.12 |
| 構造登録者 | |
| 主引用文献 | Lee, P.S.,Ohshima, N.,Stanfield, R.L.,Yu, W.,Iba, Y.,Okuno, Y.,Kurosawa, Y.,Wilson, I.A. Receptor mimicry by antibody F045-092 facilitates universal binding to the H3 subtype of influenza virus. Nat Commun, 5:3614-3614, 2014 Cited by PubMed Abstract: Influenza viruses present a significant health challenge each year, as in the H3N2 epidemic of 2012-2013. Here we describe an antibody, F045-092, that possesses broadly neutralizing activity against the entire H3 subtype and accommodates the natural variation and additional glycosylation in all strains tested from 1963 to 2011. Crystal structures of F045-092 in complex with HAs from 1975 and 2011 H3N2 viruses reveal the structural basis for its neutralization breadth through insertion of its 23-residue HCDR3 into the receptor-binding site that involves striking receptor mimicry. F045-092 extends its recognition to divergent subtypes, including H1, H2 and H13, using the enhanced avidity of its IgG to overcome lower-affinity Fab binding, as observed with other antibodies that target the receptor-binding site. This unprecedented level of antibody cross-reactivity against the H3 subtype can potentially inform on development of a pan-H3 vaccine or small-molecule therapeutics. PubMed: 24717798DOI: 10.1038/ncomms4614 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (1.5045 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






